Group 1 - The company has issued a total of 10 million convertible bonds with a face value of 100 yuan each, amounting to a total of 1 billion yuan [1][2] - The initial conversion price for the bonds was set at 90.60 yuan per share, which has been adjusted multiple times due to various corporate actions [2][3] - The latest effective conversion price is 38.65 yuan per share, following adjustments due to dividend distributions and stock repurchases [7] Group 2 - The company has the right to propose a downward adjustment of the conversion price if the stock price falls below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [8][9] - If the adjustment condition is triggered, the board will decide whether to submit a proposal for the adjustment to the shareholders' meeting for approval [9] - The company has recently experienced a situation where the stock price has been below the conversion price threshold, indicating a potential for price adjustment [9]
健帆生物: 关于预计触发转股价格向下修正条件的提示性公告